Lynn Seely
Chief Executive Officer at LYELL IMMUNOPHARMA, INC.
Net worth: 1 M $ as of 2024-03-30
Lynn Seely active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director/Board Member | 2016-04-13 | - |
| Independent Dir/Board Member | 2016-04-13 | - | |
| LYELL IMMUNOPHARMA, INC. | Director/Board Member | 2021-04-30 | - |
| Chief Executive Officer | 2022-12-14 | - | |
| President | 2022-12-14 | - | |
| Independent Dir/Board Member | 2021-04-30 | 2022-12-14 |
Career history of Lynn Seely
Former positions of Lynn Seely
| Companies | Position | Start | End |
|---|---|---|---|
| MYOVANT SCIENCES LTD. | Director/Board Member | 2016-09-30 | 2020-12-31 |
| Chief Executive Officer | 2016-05-31 | 2020-12-31 | |
| President | 2016-05-31 | - | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Chief Executive Officer | 2016-04-30 | 2020-01-03 |
| President | 2016-04-30 | 2019-12-21 | |
| MEDIVATION INC | Chief Tech/Sci/R&D Officer | 2005-02-28 | 2015-10-14 |
| Orion Acquisition Corp. II | Chief Tech/Sci/R&D Officer | 2005-05-08 | 2005-06-28 |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2002-08-31 | 2005-02-28 |
| Corgentech, Inc. | Chief Tech/Sci/R&D Officer | 2001-12-31 | 2004-12-31 |
| Cytyc Health Corp. | Chief Tech/Sci/R&D Officer | 2000-12-31 | 2001-12-31 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Lynn Seely
| University of Oklahoma | Undergraduate Degree |
| University of Oklahoma College of Medicine | Doctorate Degree |
Statistics
International
| United States | 15 |
| Switzerland | 2 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 6 |
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 5 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Private companies | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Orion Acquisition Corp. II | Finance |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
| Cytyc Health Corp. | |
| Corgentech, Inc. | Health Technology |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Lynn Seely
- Experience
